Endothelial Glycocalyx and Cardiomyocyte Damage Is Prevented by Recombinant Syndecan-1 in Acute Myocardial Infarction

The authors investigated the effects of acute myocardial infarction on endothelial nanomechanics and function and the use of exogenous recombinant syndecan-1, a major component of the endothelial glycocalyx, as recovering agent.
[The American Journal of Pathology]

Stay up-to-date with your field!

Subscribe for free weekly science newsletters.

Related News